Tudor Investment Corp
DYN icon

Tudor Investment Corp’s Dyne Therapeutics DYN Stock Holding History

Tudor Investment Corp’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.4M Sell
77,031
-70,590
-48% -$1.22M ﹤0.01% 2127
2025
Q4 		$2.89M Buy
+147,621
New +$2.8M 0.01% 1541
2025
Q2 		– Sell
-81,266
Closed -$850K – 3364
2025
Q1 		$850K Buy
81,266
+38,002
+88% +$544K ﹤0.01% 1921
2024
Q4 		$1.02M Sell
43,264
-7,219
-14% -$214K ﹤0.01% 1715
2024
Q3 		$1.81M Buy
50,483
+3,414
+7% +$136K 0.01% 1256
2024
Q2 		$1.66M Sell
47,069
-9,892
-17% -$287K 0.01% 1177
2024
Q1 		$1.62M Buy
+56,961
New +$1.29M 0.01% 1121
2023
Q2 		– Sell
-61,003
Closed -$703K – 2546
2023
Q1 		$703K Buy
61,003
+746
+1% +$9.69K 0.01% 1412
2022
Q4 		$698K Buy
60,257
+34,057
+130% +$394K 0.01% 1360
2022
Q3 		$333K Sell
26,200
-43,863
-63% -$503K 0.01% 1714
2022
Q2 		$481K Buy
70,063
+14,932
+27% +$103K 0.01% 1290
2022
Q1 		$531K Buy
55,131
+16,016
+41% +$136K 0.01% 1239
2021
Q4 		$465K Buy
+39,115
New +$550K 0.01% 1531
2021
Q3 		– Sell
-23,230
Closed -$489K – 2526
2021
Q2 		$489K Sell
23,230
-50,528
-69% -$950K 0.01% 1171
2021
Q1 		$1.15M Buy
73,758
+62,992
+585% +$1.22M 0.02% 773
2020
Q4 		$226K Sell
10,766
-2,708
-20% -$53.6K 0.01% 1202
2020
Q3 		$272K Buy
+13,474
New +$296K 0.01% 1022

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Tudor Investment Corp's DYN Position: Q1 2026 in Review

Tudor Investment Corp reduced its Dyne Therapeutics (DYN) stake by 48% in Q1 2026, selling an estimated $1.22M and leaving 77,031 shares worth $1.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2127.

Tudor Investment Corp first reported a position in DYN in Q3 2020 and has held it in 17 quarters since. The position peaked at $2.89M in Q4 2025. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • Tudor Investment Corp held 77,031 shares of Dyne Therapeutics worth $1.4M as of Q1 2026.
  • Tudor Investment Corp sold 70,590 Dyne Therapeutics shares in Q1 2026, an estimated $1.22M.
  • Dyne Therapeutics made up ﹤0.01% of Tudor Investment Corp's portfolio in Q1 2026, its #2127 holding.
  • Tudor Investment Corp first reported a position in Dyne Therapeutics in Q3 2020 and has held it in 17 quarters since.
  • Tudor Investment Corp's Dyne Therapeutics position peaked at $2.89M in Q4 2025.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.